Armenia: A chance to fight two diseases at once

Significant headway has been made in treating hepatitis C with the advent of highly effective and less toxic Direct Acting Antivirals (DDAs). DAAs also enable patients co-infected with drug-resistant tuberculosis to continue their all-essential anti-TB treatment.